HomeKNSA • NASDAQ
add
Kiniksa Pharmaceuticals Ltd
Previous close
$19.38
Day range
$19.62 - $20.40
Year range
$12.69 - $22.09
Market cap
1.42B USD
Avg Volume
388.49K
P/E ratio
235.68
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 83.40M | 34.76% |
Operating expense | 56.79M | 36.50% |
Net income | 25.24M | 465.73% |
Net profit margin | 30.26 | 319.69% |
Earnings per share | 0.35 | 483.33% |
EBITDA | 621.00K | -90.66% |
Effective tax rate | -930.08% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 206.37M | 8.27% |
Total assets | 526.32M | 14.50% |
Total liabilities | 87.48M | 37.72% |
Total equity | 438.84M | — |
Shares outstanding | 70.62M | — |
Price to book | 3.11 | — |
Return on assets | 0.04% | — |
Return on capital | 0.05% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 25.24M | 465.73% |
Cash from operations | 4.32M | 137.36% |
Cash from investing | -14.89M | 65.09% |
Cash from financing | 695.00K | -41.60% |
Net change in cash | -9.87M | 81.39% |
Free cash flow | 3.66M | 136.54% |
About
Founded
2015
Website
Employees
297